Tag: prostate cancer
What makes prostate cancer aggressive? Biology, genetics, and clinical grading explained
Prostate cancer aggressiveness is determined by histological grade (Gleason score), genetic mutations (PTEN loss, TP53, BRCA2), and clinical progression patterns.…
Celebrity Disclosure Renews Focus on Prostate Cancer Screening and Early Detection
Television presenter Jeremy Clarkson's recent disclosure of aggressive prostate cancer and remission has renewed focus on screening guidelines and early…
UK National Screening Committee Defends Stance Against Routine Prostate Cancer Screening
UK's National Screening Committee publishes detailed position statements defending evidence-based approach to prostate cancer screening decisions. New guidance addresses multicancer…
NHS England Expands Precision Radiotherapy Access to Reduce Prostate Cancer Treatment Sessions from 20 to 5
NHS England announces expansion of precision radiotherapy (SABR) for prostate cancer patients, reducing treatment sessions from 20 to 5 while…
Ceramide Metabolism May Explain Racial Disparities in Prostate Cancer Drug Response
New research reveals that differences in ceramide lipid metabolism between Black and white men may explain racial disparities in prostate…
UK Restricts Prostate Cancer Screening to High-Risk Men Only
UK health advisors restrict prostate cancer screening to men with dangerous genetic variants and family cancer histories. The targeted approach…
Prostate Cancer Affects One in Eight Men: Early Symptoms and Detection Guidelines
New data reveals one in eight men will develop prostate cancer, yet early symptoms often go unrecognized. Understanding warning signs…
Triple-Drug Therapy Extends Survival in Advanced Prostate Cancer Trial
Triple-drug combination therapy significantly improved survival outcomes in advanced prostate cancer trial. The approach combines PARP inhibition with androgen-signaling blockers…